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Central proopiomelanocortin (POMC) neurons form a potent anorexigenic network, but our
understanding of the integration of this hypothalamic circuit throughout the central nervous
system (CNS) remains incomplete. POMC neurons extend projections along the rostro-
caudal axis of the brain, and can signal with both POMC-derived peptides and fast amino
acid neurotransmitters. Although recent experimental advances in circuit-level manipula-
tion have been applied to POMC neurons, many pivotal questions still remain: how and
where do POMC neurons integrate metabolic information? Under what conditions do
POMC neurons release bioactive molecules throughout the CNS? Are GABA and gluta-
mate or neuropeptides released from POMC neurons more crucial for modulating feeding
and metabolism? Resolving the exact stoichiometry of signals evoked from POMC neu-
rons under different metabolic conditions therefore remains an ongoing endeavor. In this
review, we analyze the anatomical atlas of this network juxtaposed to the physiological
signaling of POMC neurons both in vitro and in vivo. We also consider novel genetic tools
to further characterize the function of the POMC circuit in vivo. Our goal is to synthesize
a global view of the POMC network, and to highlight gaps that require further research to
expand our knowledge on how these neurons modulate energy balance.
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INTRODUCTION
Proopiomelanocortin (POMC) neurons originating from the
arcuate nucleus of the hypothalamus (ARC) are unequivocally
important for maintaining metabolic homeostasis (Cone, 2005;
Smart et al., 2006). The requirement of the central POMC neu-
ronal network for energy balance has been established for almost
20 years, but precisely how an organism synthesizes and trans-
mits information through hypothalamic POMC neurons remains
enigmatic. This class of anorexigenic neurons is defined by the
expression of the Pomc gene and its downstream peptide products:
α-melanocyte stimulating hormone (α-MSH), β-MSH, γ-MSH,
adrenocorticotropic hormone (ACTH), and β-endorphin (Moun-
tjoy, 2010). α- and β-MSH are central to metabolic regulation
through activation of the melanocortin 4 (MCR4) and MCR3
receptors, whereas γ-MSH is most potent at MCR3 (Roselli-
Rehfuss et al., 1993). Agonism of these two receptors inhibits
feeding behavior, promotes energy expenditure, and modulates
energy partitioning (Roselli-Rehfuss et al., 1993; Harrold et al.,
1999; Butler et al., 2000; Hwa et al., 2001). Furthermore, deficien-
cies in neural Pomc gene expression and melanocortin peptide
production (Krude et al., 1998; Yaswen et al., 1999; Lee et al., 2006;
Smart et al., 2006) or postsynaptic MCR function (Biebermann
et al., 2006; Lee et al., 2008; Mencarelli et al., 2008) induce severe
hyperphagia, reduced metabolic output, and weight gain.
The three primary central nervous system (CNS) opioids (β-
endorphin, enkephalins, and dynorphins) are mixed agonists for
µ-, κ-, and δ-opioid receptors. Stimulation of the centralµ-opioid
receptor system, in particular, by infusion of peptides including β-
endorphin or synthetic agonists, is widely regarded to increase
body mass and food intake, particularly of hedonically preferred
macronutrients (Olszewski et al., 2011; DiFeliceantonio et al.,
2012). Despite these actions of exogenously administered opi-
oids, genetic ablation of β-endorphin from Pomc by insertion of
a premature STOP codon results in a body weight increase of
10–15% due to increased fat storage in young male mice (Rubin-
stein et al., 1996; Low et al., 2003). Behavioral tests suggest that
β-endorphin is a critical component of food reward circuitry
(Hayward et al., 2002), but this opioid may also synergize with
α-MSH to increase metabolic output and decrease food con-
sumption long-term (Appleyard et al., 2003; Low et al., 2003).
At the cellular level, β-endorphin can also directly modify POMC
neuron activity by antagonizing the effects of α-MSH on down-
stream MCRs (Dutia et al., 2012) and by inhibiting POMC neurons
throughµ-opioid receptors (Pennock et al., 2012). Taken together,
the peptide milieu released from POMC neurons is anorectic, but
with a caveat: α-MSH is a direct suppressor of food intake, sig-
naling through downstream MCRs, whereas β-endorphin, despite
its apparent role in promoting hypophagia and fat metabolism,
can directly temper POMC neuron and α-MSH activity. It is inter-
esting to note, however, that the sensitivity to opioids is much
greater at presynaptic µ-opioid receptors regulating POMC neu-
rons than at the postsynaptic receptors (Pennock and Hentges,
www.frontiersin.org February 2013 | Volume 7 | Article 19 | 1
Mercer et al. Physiological integration of proopiomelanocortin neurons
2011). Therefore, since the majority of inputs to POMC neurons
are inhibitory, it may be that endogenous opioids inhibit the
presynaptic release of GABA onto POMC neurons, and thus disin-
hibit POMC neurons. Consistent with this possibility, recent work
shows that optogenetically induced release of β-endorphin inhibits
presynaptic transmitter release onto ARC AgRP neurons without
causing a notable postsynaptic effect (Yang et al., 2011). Further-
more, a recent study demonstrated that dynorphin can directly
inhibit the activity of POMC neurons via κ2 receptors located on
the cell body and dendrites, while altering presynaptic tone via
κ1 receptors located on axon terminals (Zhang and van den Pol,
2013).
Proopiomelanocortin neurons can be identified by virtue of
Pomc gene and melanocortin or β-endorphin peptide expres-
sion. However, these cells exhibit diverse anatomical connec-
tions and neurochemical profiles. The dendrites, presumptive
sites of synaptic inputs in addition to the POMC cell somas,
currently remain largely intractable to analysis. Emerging evi-
dence also indicates that subpopulations of POMC neurons have
the capacity to signal with both neuropeptides and amino acid
neurotransmitters (Hentges et al., 2004, 2009; Dicken et al.,
2012) and that these hypothalamic neuroendocrine cells inte-
grate signals at sites distal to the ARC (Hentges, 2007). Taken
together, POMC neurons have a tremendous capacity for integrat-
ing peripheral and central metabolic cues, while releasing both
peptides and amino acid transmitters throughout the CNS. In
this review, we examine the heterogeneous population of POMC
neurons to synthesize a more complete picture of this circuit.
To close, we consider recent advances in transgenic mouse lines
as well as circuit-level analysis with new tools such as optoge-
netics and designer receptors exclusively activated by designer
drugs (DREADD) technology. These advanced technologies are
essential to further elucidate the function of this network in
the context of energy balance, as significant gaps still exist
regarding POMC anatomy and physiology in the CNS. A more
complete understanding of the POMC neural network is crit-
ical to determine its function in obesity and related metabolic
disorders.
LIGHT MICROSCOPIC ANATOMY OF THE CENTRAL POMC
SYSTEM
The primary population of CNS POMC-expressing neurons con-
sists of a few thousand cells spanning the entire rostrocaudal extent
of the ARC and within the periarcuate region. In Mus musculus,
there are ∼3,000 total POMC neurons in the mediobasal hypo-
thalamus (Cowley et al., 2001; Plum et al., 2009) that extend fibers
to multiple nuclei throughout the CNS (Cone, 2005; Hentges,
2007; King and Hentges, 2011; Lim et al., 2012). This distri-
bution parallels the anatomy of POMC cell bodies and fibers
identified on the basis of peptidergic immunoreactivity in the rat,
human, and macaque brain (Desy and Pelletier, 1978; Jacobowitz
and O’Donohue, 1978; Watson et al., 1978; Khachaturian et al.,
1984). For consistency, our discussion of the ultrastructural mor-
phology of POMC neurons will focus on observations in the rat,
whereas modern approaches in genetics, anatomy, and physiology
described in this review will primarily focus on our understanding
of the POMC circuit in mice.
Predominant CNS regions containing POMC peptide
immunoreactive fibers include nuclei implicated in feeding (ARC,
paraventricular nucleus of the hypothalamus (PVH), lateral hypo-
thalamus, and nucleus tractus solitarius (NTS); Cone, 2005; Zheng
et al., 2010), reward (bed nucleus of the stria terminalis, nucleus
accumbens, septal nucleus, ventral tegmental area, and central
amygdala; Arvaniti et al., 2001; Pandit et al., 2011; Lim et al.,
2012), and analgesia (periaqueductal gray, dorsal raphe nucleus;
Chen et al., 1992; Wang et al., 1998). These axonal projections
parallel the patterns of MCR (Gantz et al., 1993; Roselli-Rehfuss
et al., 1993; Mountjoy et al., 1994) and opioid receptor (Minami
and Satoh, 1995) expression, suggesting a relatively tight pre- and
postsynaptic juxtaposition of POMC peptide release sites to MCR-
or µ-opioid expressing effector cells. An additional small popu-
lation of ∼300 POMC neurons is found in the NTS (Palkovits
and Eskay, 1987; Joseph and Michael, 1988). Although it has
been suggested that NTS POMC neurons assist in integrating gut
and CNS feeding signals (Joseph et al., 1983; Corp et al., 1998;
Grill et al., 1998), selective ablation of the ventral hypothalamus
reduces POMC-positive fiber immunoreactivity in the brainstem
by over two-thirds (Kitahama et al., 1986; Joseph and Michael,
1988; Barna et al., 1997; Zheng et al., 2010) and thus, POMC
projections emanating from the ARC appear to be the principal
signaling unit for Pomc-derived peptides throughout the CNS in
adult animals.
ULTRASTRUCTURAL ORGANIZATION OF POMC NEURONS
Ultrastructural analyses of POMC neurons described cell bod-
ies 20–30µm in diameter, with prominent organelles for peptide
synthesis (Bugnon et al., 1981; Lamberts and Goldsmith, 1985)
including an abundant rough endoplasmic reticulum and exten-
sive Golgi complexes that extended from the perinuclear zone to
the axon hillock. It should be noted that the anatomy character-
ized in these studies was performed on animals pre-treated with
colchicine, resulting in an increased cytoplasmic accumulation of
small, clear vesicles, and dense core granules. While this tech-
nique allows for neurochemical identification at the level of the
perikarya, it does not resolve the location of endogenous release
sites. However, in these studies, golgi complexes exhibited a close
association with both dense core granules and vesicles, indicat-
ing that, at the ultrastructural level, POMC neurons might have
the capacity to release both amino acid neurotransmitters and
secretory peptides. Pre-embedding immunoelectron microscopy
revealed that both small clear vesicles and dense core granules traf-
fic to the axons and synapses of POMC neurons identified in the
ARC (Matsumoto and Arai, 1978; Kiss and Williams, 1983; Buma
et al., 1989). Other neurosecretory systems also have the capacity
to release peptides from the soma or dendritic arbors (Morris and
Pow, 1991; Huang and Neher, 1996; Ludwig et al., 2002), but these
mechanisms appear to be cell-type specific (Ramamoorthy et al.,
2011). POMC neurons indeed have large, clear vesicles present in
dendritic branches (Leranth et al., 1980), but whether these vesi-
cles are utilized for the dendritic release of peptides or amino acid
neurotransmitters has not been determined.
Unidentified neurons originating in the ARC contain an average
of two or three dendrites, which are spatially oriented depen-
dent on the proximity of the soma to the third ventricle (van
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den Pol and Cassidy, 1982). Dendrites from medial neurons are
oriented in the dorsoventral axis, while lateral neurons preferen-
tially project mediolaterally. Moreover, ARC neurons characteris-
tically have thin, tapering dendrites instead of a dense, branched
dendritic plexus. Axons from ARC neurons either terminate at
synapses on other local neurons, or bifurcate and send one col-
lateral within the ARC and extend a second fiber to another
nucleus (van den Pol and Cassidy, 1982). POMC neurons reca-
pitulate this generalized description: multiple thin dendrites are
found on POMC neurons within the ARC, while tapered, elon-
gated processes extend hundreds of µm along the dorsoventral
axis (Hentges, 2007). Although dendrites are considered the tradi-
tional“input”branch of a cell, POMC neurons are also synaptically
innervated directly on their cell somas (Horvath et al., 1992,
2010; Guan et al., 2008). Axon terminals from POMC neurons
exist both within the ARC near POMC somas (Matsumoto and
Arai, 1978; Chen and Pelletier, 1983; Cowley et al., 2001; Hent-
ges et al., 2004, 2009), and also at distal sites throughout the
diencephalon and mesencephalon (Zheng et al., 2010; King and
Hentges, 2011). Thus, both inputs to and outputs from POMC
neurons occur locally within the ARC as well as some distance
from the ARC.
CENTRAL INPUTS TO POMC NEURONS
Techniques utilized in the handful of studies examining POMC
dendrites have been limited by several drawbacks. The Golgi stain-
ing technique (van den Pol and Cassidy, 1982) provided robust
labeling, but the authors were unable to specifically identify POMC
neurons, and they did not examine distal processes outside of
the ARC. Similarly, analyses of POMC neurons labeled intracel-
lularly with neurobiotin (Hentges, 2007) are limited by dialysis
of the biotin solution and the fact that cells in tissue slices will
have some of their distal processes cut during slice preparation.
Nonetheless, both approaches indicate the relative lack of spines
on dendritic processes, which makes the identification of POMC
dendrites more difficult (Liu et al., 2012). Therefore, our knowl-
edge of the dendritic organization of POMC neurons is far from
complete.
Comparatively, the established anatomical dogma for hypothal-
amic gonadotropin-releasing hormone (GnRH) neurons is that
of a relatively simple bipolar morphology with one or two den-
drites. Recently, Herde et al. (2011) showed that a subpopulation
of GnRH neurons have highly branched dendrites that extend
beyond the blood-brain barrier (BBB) into the organum vascu-
losum of the lamina terminalis (OVLT). In this region, GnRH
neurons can directly sense molecules circulating in the blood-
stream, and the branched dendritic network can putatively provide
a large surface area for efficient sampling. ARC POMC neurons,
on the other hand, are located just dorsal to the median eminence,
sending fibers throughout its entirety (Kiss et al., 1985). Simi-
lar to the OVLT, the fenestrated microcapillaries surrounding the
median eminence (Golding, 1994; Meister, 2007; Norsted et al.,
2008) may allow POMC fibers, including both axons and den-
drites, to directly transmit and receive signals outside of the CNS.
These new findings in GnRH neurons advocate parallel studies of
POMC dendrites to better understand the integration of metabolic
signals through POMC networks.
Peptidergic and amino acid neurotransmitter inputs driving
POMC neuronal activity have been studied from the level of ani-
mal behavior down to single cell electrophysiological responses,
and it is therefore out of the scope of this review to cover
the literature on this subject in its entirety. Likewise, the effects
of peripheral hormones such as leptin and insulin on central
POMC neurons have been recently reviewed at length (Mor-
ton and Schwartz, 2011; Williams et al., 2011). Instead, we will
focus on the primary CNS circuits that impinge upon POMC
neurons.
AgRP/NPY/GABA NEURONS
The classic antagonistic circuit to POMC neurons includes a sep-
arate population of cells in the ARC, the neuropeptide-Y/agouti-
related peptide (NPY/AgRP) neurons. NPY/AgRP neurons release
three transmitters reported to stimulate feeding: AgRP, NPY, and
γ-aminobutyric acid (GABA; Wu and Palmiter, 2011). AgRP was
initially discovered to be a potent inhibitor of MCR function
(Ollmann et al., 1997), and was subsequently characterized as an
inverse agonist of MC3R and MC4R activity in vitro and in vivo
(Shutter et al., 1997; Haskell-Luevano and Monck, 2001; Nijenhuis
et al., 2001; Tolle and Low, 2008). However, a second in vivo exper-
iment suggested that AgRP might function only as a competitive
MCR antagonist without inverse agonist actions (Corander et al.,
2011). In these studies, double-knockout mice lacking both Pomc
and Agrp (Pomc−/−;Agrp−/−) recapitulated the obesogenic pheno-
type observed in Pomc−/− single knockouts,questioning the ability
of CNS AgRP to promote an orexigenic phenotype independently
of endogenous melanocortin peptides. Further pharmacological
approaches in Pomc−/−; Agrp−/− mice indicated that exogenous
AgRP could antagonize the effects of α-MSH on feeding, but AgRP
peptide alone did not enhance the already increased feeding behav-
ior of these mice. Along the same lines, AgRP may also negatively
shift the constitutive activity of the MCRs, or induce the endo-
cytosis of target MCRs (Breit et al., 2006). A final consensus on
the mechanism of action by AgRP on MCRs is still being debated
(Flier, 2006), but AgRP nonetheless appears to negatively regulate
downstream MCRs. In addition to inhibitory effects on MCRs,
AgRP, and GABA release from AgRP/NPY neurons can evoke a
hyperpolarizing response directly on ARC POMC neurons (Smith
et al., 2007; Tong et al., 2008). NPY also hyperpolarizes POMC
neurons through the neuropeptide-Y receptor 1-activation of G-
protein inwardly rectifying potassium channels (Roseberry et al.,
2004). At the histochemical and ultrastructural level, AgRP neu-
rons impinge upon the perikarya of POMC neurons throughout
the ARC (Horvath et al., 1992, 2010; Newton et al., 2013), and these
neurons can directly inhibit POMC neurons through the synap-
tic release of GABA (Atasoy et al., 2012). Thus, AgRP neurons
can negatively modulate POMC function by a direct GABAergic
synaptic mechanism and indirectly by antagonizing postsynaptic
MCRs.
Although NPY exhibits diverse functions throughout the brain
(Redrobe et al., 2002; Dube, 2007), AgRP neurons exhibit >99%
co-localization with NPY in the ARC. While the orexigenic func-
tion of AgRP and NPY peptides is well documented (Ollmann
et al., 1997; Hollopeter et al., 1998; Rossi et al., 1998), further stud-
ies have probed which transmitter released by AgRP/NPY neurons
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is critical for the positive modulation of feeding behavior. Con-
stitutive knockouts of Agrp and Npy genes or downstream NPY
receptors in mice failed to produce feeding or body weight deficits,
and these mice responded normally with compensatory increased
feeding behavior in response to food-restriction (Palmiter et al.,
1998; Qian et al., 2002; Thorsell and Heilig, 2002; Corander et al.,
2011). Knock-in mice harboring Npy alleles with a tetracycline-
off (Tet-Off) regulatory domain and a minimal promoter inserted
into exon 1 were developed to examine the necessity of NPY to pro-
mote feeding behavior (Ste Marie et al., 2005). The mutant allele
produced a fourfold constitutive elevation in Npy mRNA, while
administration of doxycycline greatly reduced the levels of Npy
mRNA and NPY protein measured in the whole brain of these
mice compared to control animals. Conspicuously, these func-
tional gene dosage manipulations also failed to induce phenotypic
alterations in body weight homeostasis (Ste Marie et al., 2005). It
has been suggested that in the cases of early developmental abla-
tion of NPY/AgRP neurons, gradual adult depletion of NPY/AgRP
neurons, or gradual reduction in levels of NPY peptides, the CNS
circuitry makes compensatory adaptations for the loss of signaling
from these neurons (Ste Marie et al., 2005; Pierce and Xu, 2010;
Wu and Palmiter, 2011).
A persuasive body of evidence has accumulated that GABA
released from NPY/AgRP neurons is the critical transmitter modu-
lating feeding behavior, as the severe anorectic phenotype induced
by the acute ablation of AgRP neurons by diptheria toxin in adult
mice can be rescued with chronic infusion of a benzodiazepine
partial agonist (Wu et al., 2008, 2009). Along the same lines, selec-
tive deletion of the GABA/Glycine-specific vesicular transporter
VGAT from AgRP neurons results in lean mice that are resistant
to obesity (Tong et al., 2008). Despite the antagonistic effects of
AgRP on MCRs, it is hypothesized that the inhibitory effects of
GABA may be the primary mechanism by which AgRP neurons
counter the POMC network throughout the CNS. While GABA
release from AgRP neurons can directly inhibit POMC neurons,
it also inhibits neurons in the parabrachial nucleus (PBN), which
is a relay center that integrates information about feeding, nausea,
and taste aversion (Wu et al., 2012a).
An alternative explanation for the orexigenic nature of
NPY/AgRP neurons, based on recent optogenetic experiments, is
that these neurons primarily target oxytocin neurons within the
PVH to enhance feeding behavior (Atasoy et al., 2012). Oxytocin
neurons are direct targets of both NPY/AgRP and POMC neu-
rons due to their expression of MCRs (Sabatier et al., 2003), and
therefore NPY/AgRP neurons can inhibit oxytocin neurons by a
combination of MCR antagonism and GABA transmission. How-
ever, depleting central oxytocin neurons postnatally elicits mini-
mal effects on feeding behavior, and instead results in animals that
are only prone to high fat diet-induced obesity (Wu et al., 2012b).
Despite these disparate findings, AgRP neurons may impinge both
on oxytocin neurons to inhibit energy expenditure (Wu et al.,
2012b) and promote feeding (Atasoy et al., 2012), while reinforc-
ing the hedonic component of feeding by signaling in the PBN
(Wu et al., 2012a). While questions remain regarding the detailed
mechanisms of AgRP neuron actions, technological advances in
circuit-level manipulations of transgenic mice reinforce that AgRP
neuron activation results in positive energy balance, positing that
AgRP neurons are a primary circuit in the CNS that opposes many
functions of ARC POMC neurons (Aponte et al., 2011; Krashes
et al., 2011).
SEROTONERGIC NEURONS
In the late twentieth century, the drug fenfluramine was utilized as
an appetite suppressant. Fenfluramine stimulates the central sero-
tonergic (5-HT) system, which led to potent weight loss effects
in patients (Halford et al., 2011). Problematically, the drug had
off-target effects in the cardiovascular system, and its use as a
weight loss medication was discontinued in the mid-to-late 1990s.
Nonetheless, the effects of fenfluramine on the CNS were fur-
ther probed in animal models, and it was revealed that the effects
of 5-HT stimulation resulted in the activation of POMC neu-
rons in the ARC (Heisler et al., 2002; Giorgetti and Tecott, 2004).
Global knockout of the 5-HT2C receptor (5-HT2CR) induced
pronounced hyperphagia, hyperactivity, and obesity in mice, but
selective re-expression of 5-HT2CRs in POMC neurons resulted
in the normalization of body composition, feeding behavior, and
peripheral insulin sensitivity (Xu et al., 2008, 2010a). These results
were further extended to downstream MCR-expressing neurons,
and it was found that fenfluramine stimulated POMC neurons
to release melanocortin peptides onto cognate MC3R and MC4R
throughout the CNS (Lam et al., 2008; Rowland et al., 2010; Xu
et al., 2010b).
The exact intracellular mechanism by which 5-HT2CRs induce
a depolarization of POMC neurons is unclear. 5-HT2CRs are Gq G-
protein coupled receptors (GPCRs) that generally stimulate neu-
rons through phospholipase C intracellular cascades (Lam et al.,
2010). In this cascade, activated phospholipase C cleaves phos-
phatidylinositol 4,5-bisphosphate into diacyl glycerol and inositol
1,4,5-bisphosphate (IP3). Among other functions, IP3 can stim-
ulate the release of intracellular Ca2+ stores in the endoplasmic
reticulum,which can result in increased granule and vesicle release.
It has also been reported that serotonin activates transient receptor
potential channels (TRPC; Sohn et al., 2011), similar to leptin sig-
naling (Qiu et al., 2010). Others have shown that serotonin blunts
the function of potassium channels, which act to hyperpolarize the
cell’s resting membrane potential, in POMC neurons (Qiu et al.,
2007; Roepke et al., 2012). Taken together, after 5-HT2CR activa-
tion these mechanisms can all induce a depolarizing response and
lead to the firing of action potentials by POMC neurons.
The entire serotonergic circuit originates from the dorsal and
ventral raphe nuclei, but the primary inputs to ARC POMC neu-
rons appear to project from the B7 subnucleus of the dorsal raphe
(Lam and Heisler, 2007). Similar to the phenotypic heterogene-
ity observed in insulin- versus leptin-sensitive POMC neurons
(Williams et al., 2010), individual POMC neurons have been
reported to be activated by leptin or serotonin, but not both lig-
ands (Sohn et al., 2011). In these studies, the authors mapped the
activity of POMC neurons in the ARC based on a given transmitter
stimulus. Serotonin-sensitive neurons lay more medial and rostral
in the ARC, whereas leptin-sensitive neurons map to more late-
rocaudal portions of the ARC. Insulin-sensitive POMC neurons
are distributed similarly to serotonin-sensitive POMC neurons,
but it is unclear if these two populations are anatomically dis-
tinct or if they can respond to both effectors. This heterogeneity,
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however, begets larger questions: are subpopulations of POMC
neurons more critical than others to modulate feeding behavior
and energy expenditure? Do these different populations exert dif-
ferent metabolic effects? Selective deletion of leptin and insulin
receptors from POMC neurons resulted in only a mild obeso-
genic phenotype (Balthasar et al., 2004; Hill et al., 2010), whereas
a global knockout and subsequent POMC-specific rescue of 5-
HT2CR expression normalized mice that were initially hyperphagic
and obese (Xu et al., 2008). Despite tools to specifically manipu-
late receptor expression in POMC neurons, leptin, serotonin, and
insulin are all regarded to exert potent effects on feeding behavior,
energy expenditure, and glucose homeostasis (Hill et al., 2010;
Williams et al., 2011). Thus, corroborating the diverse POMC
population with other CNS circuits and peripheral targets is an
ongoing effort in the field of metabolism research.
POMC SYNAPSES
To release bioactive signaling molecules, POMC neurons inte-
grate afferent signals until a depolarization induces the release
of peptidergic vesicles and granules in a calcium-dependent man-
ner (O’Donohue et al., 1981; Bunel et al., 1990). In ex vivo brain
slices, POMC neurons exhibit a canonical pathway to release
peptidergic granules: the opening of voltage-gated sodium chan-
nels propagates an action potential which results in an influx of
Ca2+ through voltage-gated calcium channels to release α-MSH-
containing granules (Tiligada and Wilson, 1988; Tranchand Bunel
et al., 1989). Basal release of POMC peptides, however, appears
to operate independently of depolarization-induced Ca2+ influx
(Jegou et al., 1987), possibly by capitalizing on intracellular stores
of Ca2+ within the endoplasmic reticulum. At the synapse, Ca2+
presumably induces SNARE machinery to intertwine with surface
glycoproteins on synaptic vesicles and granules to release peptides
and transmitters into the synaptic cleft. Although POMC neu-
rons are typically characterized by the expression and release of
POMC-derived neuropeptides, almost all POMC neurons express
the cocaine- and amphetamine-regulated transcript (Cart ) gene
and encoded CART peptide (Elias et al., 1998) and∼30% also show
co-localization with prodynorphin immunoreactivity (Maolood
and Meister, 2008; Zhang and van den Pol, 2013).
POMC-DERIVED PEPTIDES AND PEPTIDE-RECEPTOR MISMATCH
As α-MSH, β-endorphin, and ACTH are all POMC-derived pep-
tide products, the axonal fibers, and synaptic terminals of central
POMC neurons exhibit unequivocal expression of these three
peptides across species (O’Donohue and Dorsa, 1982; Chen and
Pelletier, 1983; Kiss and Williams, 1983; Dores and Baron, 2011).
Because fibers immunoreactive for POMC peptides co-ramify
in target nuclei expressing either MCRs or opioid receptors, a
simplistic scheme would suggest that POMC boutons and presy-
naptic terminals directly release neuropeptides onto other neurons
expressing the appropriate receptors. However, neuroendocrine
circuits such as the POMC system exhibit an interesting paradox:
peptides released from POMC neurons can be detected at sites
devoid of postsynaptic receptors (MacMillan et al., 1998), and at
the ultrastructural level, neurons within the hypothalamus includ-
ing presumptive POMC neurons appear to have the machinery to
release peptides at non-synaptic sites as well (Leranth et al., 1980;
Buma and Nieuwenhuys, 1988; Buma et al., 1989; van Lookeren
Campagne et al., 1991). It has been suggested that circuits like
the central POMC system may participate in both synaptic and
volume transmission in the CNS (Golding, 1994; Agnati et al.,
1995; van den Pol, 2012). Although POMC neurons form classi-
cally described synaptic contacts with postsynaptic dendritic fibers
(Bugnon et al., 1981), they also exocytose neuropeptides into the
ventricular circulation. POMC fibers straddle the cerebral ventri-
cles along the rostrocaudal extent of the brain (Cone, 2005), and it
has been demonstrated that POMC and POMC-derived peptides
circulate throughout the ventricular network, possibly to act on
distal target sites irrespective of a direct POMC synaptic contact
(Kaye et al., 1987; Tsigos et al., 1993; Veening et al., 2012). This idea
is recapitulated by the fact that intracerebroventricular adminis-
tration of melanocortin agonists reduces feeding and body weight
in experimental animals (Murphy et al., 1998, 2000), whereas
melanocortin antagonists applied by the same route induce hyper-
phagia and weight gain (Rossi et al., 1998; Irani et al., 2011). In
contrast to this view, focal injections of melanocortin agonists
in the hypothalamus (Giraudo et al., 1998; Kim et al., 2000) or
brainstem (Grill et al., 1998; Williams et al., 2000; Sutton et al.,
2005; Zheng et al., 2005) reduce food intake and promote weight
loss, suggesting that POMC neurons indeed have specified effec-
tor targets that, at least in part, are required to maintain metabolic
homeostasis.
Proopiomelanocortin peptides may also be released at non-
synaptic sites to act as paracrine signals. For example, chronic
neuropathic pain is associated with phosphorylation and desensi-
tization of µ-opioid receptors in the dorsal striatum of wild-type
mice. These receptor events are blocked in β-endorphin knockout
mice, but retained in proenkephalin or prodynorphin knockout
mice, suggesting that β-endorphin is the endogenous opioid pep-
tide that physiologically interacts with striatal µ-receptors in this
experimental paradigm (Petraschka et al., 2007). However, there
are no POMC or β-endorphin immunoreactive fibers in the stria-
tum of wild-type mice indicating that the source of β-endorphin
must be at some distance from its target requiring diffusion of the
peptide from its site of release, possibly via the cerebrospinal fluid.
GABA AND GLUTAMATE RELEASE FROM POMC NEURONS
Ultrastructural observations of POMC synapses revealed large
dense core granules that were immunopositive for POMC pep-
tides, but also small, clear vesicles localized to synaptic terminals
(Kiss et al., 1984; Buma et al., 1989). The morphological properties
of POMC vesicles matched that of vesicles in synapses through-
out the CNS. Electron microscopic measurements of such vesicles
are described as small, clear compartments with a diameter of
∼50 nm concentrated at active zones in presynaptic terminals
(Heuser, 1989). The central POMC circuit has been described to
have subpopulations of cells that are glutamatergic or cholinergic
(Ovesjo et al., 2001; Collin et al., 2003; Meister et al., 2006; Meis-
ter, 2007), but these studies were limited to immunohistochemical
descriptions of the ARC.
We developed an in vitro culture system of neurons expressing
fluorophores under control of Pomc transgenes that allowed an
electrophysiological characterization of identified neurons (Hent-
ges et al., 2004, 2009). Cultured primary neurons maintained for
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2 weeks prior to experimentation formed autaptic synapses, which
proved useful for single neuron unit dissection of the amino acid
neurotransmitter phenotypes in these cells. Patch-clamp record-
ings revealed both GABAergic and glutamatergic subpopulations
of POMC neurons. In acute brain slices, electrophysiological, and
channelrhodopsin-based stimulation of POMC neurons induced
evoked release of both GABA and glutamate (Dicken et al., 2012;
Pennock et al., 2012) indicating the ability of these neurons to
release amino acid transmitters in an intact circuit and exclud-
ing the possibility of artifactual results from the earlier in vitro
experiments. Consistent with GABA release,∼40% of POMC neu-
rons express the GABA-synthesizing enzymes GAD67 and GAD65
(Hentges et al., 2004; Jarvie and Hentges, 2012). To load synap-
tic vesicles with GABA, the canonical VGAT molecule traverses the
vesicle membrane and loads GABA in a proton-dependent manner
(Gasnier, 2004). Furthermore, a smaller fraction of POMC neu-
rons express the vesicular glutamate transporter VGLUT2 (Collin
et al., 2003; Vong et al., 2011; Jarvie and Hentges, 2012), consistent
with the finding of glutamate release from some POMC neurons.
A dissenting view regarding the existence of GABAergic POMC
neurons was published recently: neurons in the CNS expressing a
tdTomato marker following Cre-recombinase mediated deletion
of a loxP-flanked stop signal by a VGAT-Cre transgene did not
overlap with Pomc-hrGFP neurons (Vong et al., 2011). However,
POMC neurons express the enzymes to synthesize GABA (Hentges
et al., 2004; Jarvie and Hentges, 2012) and the synaptic machinery
to release GABAergic vesicles in isolated POMC cultures (Hent-
ges et al., 2004, 2009) and in acute brain slices (Dicken et al.,
2012). Because POMC neurons do not appear to express standard
VGAT isoforms, it is likely that they use an unidentified transporter
protein or an alternative mechanism to load vesicles with GABA.
Dopaminergic neurons in the substantia nigra pars compacta can
release GABA in a VGAT-independent manner by instead load-
ing GABA into vesicles using the vesicular monoamine transport
protein 2 (VMAT2; Tritsch et al., 2012). These researchers also
discovered that VMAT2 is sufficient to restore GABA loading and
release in Vgat−/− neurons. A similar mechanism may load GABA
into vesicles in POMC neurons, but to date this has not been
examined.
At the ultrastructural level in M. musculus, POMC presynaptic
terminals contain both POMC peptides and amino acid neuro-
transmitters (C. K. Meshul and M. J. Low, unpublished observa-
tions). Using transgenic mice expressing enhanced GFP (EGFP)
under control of the Pomc promoter (Cowley et al., 2001), axon
terminals from POMC neurons were identified by pre-embedding
immunohistochemistry and electron microscopy following the
methods of Meshul and McGinty (Meshul et al., 1994, 1999;
Meshul and McGinty, 2000). POMC neurons were identified using
primary antisera to GFP or ACTH and visualized using biotiny-
lated secondary antibodies and an avidin-coupled DAB reaction
product, whereas GABA and glutamate were detected at EGFP-
and ACTH-positive synaptic terminals with immunogold-coupled
antibodies.
Proopiomelanocortin axon terminals were readily identified
as GABAergic or glutamatergic in these preparations. Bona fide
POMC terminals were identified based on their combination
of electron-dense DAB reaction product, content of synaptic
vesicles and granules, and the presence of characteristic synap-
tic plasma membrane specializations at the juxtaposition of the
terminal to a postsynaptic dendritic process or soma. GABA
or glutamate immunogold-labeled presynaptic terminals formed
symmetric or asymmetric synaptic contacts to postsynaptic neu-
rons, respectively. These terminals contained >10 gold parti-
cles per µm2, determined to be the minimum concentration of
labeled transmitter particles to identify positively labeled axon
terminals above background signal. Qualitatively, GABA-positive
nerve terminals exhibited the greater density of immunoreac-
tive amino acid neurotransmitter in POMC-positive nerve ter-
minals and were identified more readily in ultra-thin sections,
consistent with the finding that ∼40% of the central POMC
circuit is GABAergic (Jarvie and Hentges, 2012). Glutamatergic
POMC neuron terminals on the other hand, were much rarer,
but nevertheless expressed glutamate in association with synaptic
vesicles.
Interestingly, GABAergic and glutamatergic POMC neurons
combined appear to comprise only 50% of the entire network.
Gad65 and Gad67 mRNAs are expressed in predominately over-
lapping populations of POMC neurons, therefore about 50% of
the POMC neurons in the ARC lack detectable markers indica-
tive of GABA or glutamate phenotypes under basal conditions (S.
T. Hentges, unpublished observation). The possibility that more
POMC neurons could be identified as GABAergic or glutamatergic
under different conditions, such as when energy balance is per-
turbed, has not yet been explored. In addition to GABAergic and
glutamatergic phenotypes, immunohistochemical evidence sug-
gests that a few POMC cells may be cholinergic (Meister et al.,
2006). We have not observed cholinergic POMC neurons using
in situ hybridization or electrophysiological approaches, and it
remains to be determined if cholinergic markers co-localize with
amino acid transmitters in POMC neurons. It is possible that a
subpopulation of POMC neurons may have no additional neuro-
chemical phenotype, releasing only POMC and CART peptides.
However, this possibility will be difficult to definitively demon-
strate since identifying the diverse neurochemical phenotypes at
POMC synapses may be hampered by amino acid transmitter lev-
els that are below the threshold of detection for many standard
neuroanatomical techniques.
PHYSIOLOGIC CONSEQUENCES OF ACTIVATING POMC
NEURONS
In a recent study, Aponte et al. (2011) activated POMC or AgRP
networks using channelrhodopsin-based photostimulation. Pho-
tostimulation of AgRP neurons induced a robust hyperphagic
response within 1 h, whereas activation of POMC neurons using
the same technology required a 24-h stimulation to dampen feed-
ing in transgenic mice. Although in vivo evidence suggests a much
more prolonged time scale for a POMC-dependent decrease in
appetitive behavior, ex vivo brain slice recordings show that chan-
nelrhodopsin expressing POMC neurons can release an opioid
(presumably β-endorphin) in response to acute photostimulation
(Yang et al., 2011). The evidence that β-endorphin can act in an
auto-inhibitory fashion on presynaptic POMC neurons may at
least partially explain the delay in feeding cessation in optically
stimulated POMC neurons (Pennock et al., 2012). The work by
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Yang et al. postulates that POMC neurons can inhibit presynap-
tic glutamatergic inputs to AgRP/NPY neurons in an opioidergic
fashion, but it is unclear how robustly this mechanism affects
AgRP/NPY neurons in vivo. The slice preparation experiments
indicate that POMC neurons, however, can directly affect the
tone of a counter-regulatory ARC circuit by an evoked stimu-
lus. Despite the rapid actions noted in the slice preparation, the
in vivo optogenetic studies suggest varied possibilities for POMC
peptide signaling: (1) a significant stimulus over time is required
to elicit a response on feeding behavior, (2) POMC peptides dif-
fuse slowly to their targets in the CNS, (3) that activation of
POMC neurons may affect food intake preferentially under cer-
tain conditions, such as at the onset of the dark cycle when POMC
neurons are usually inhibited, or (4) that very specific patterns
of stimulation are required to adequately recapitulate the firing
patterns of POMC neurons in vivo. To date it is unclear what
physiological stimuli regulate the spatiotemporal release of pep-
tides versus amino acid transmitters, and therefore it remains to be
seen how different combinations of neurotransmitters and pep-
tides affect postsynaptic neurons. For example, POMC neurons
may release α-MSH to activate a postsynaptic MCR-expressing
cell, but this effect may be dampened if a POMC presynaptic ter-
minal co-releases GABA. Along the same lines, a central infusion
of β-endorphin can blunt the anorectic effects of centrally applied
α-MSH (Dutia et al., 2012) despite the fact that both endoge-
nous peptides originate from POMC neurons and presumably
are co-released from POMC projections. While all POMC neu-
rons express α-MSH, β-endorphin, and ACTH, we do not know
if these peptides are present in equal proportions in all POMC
fibers throughout the brain. Thus, POMC neurons may modu-
late postsynaptic neurons differentially depending on their explicit
neurochemical profile.
STOICHIOMETRY AND PLASTICITY OF THE CENTRAL POMC
CIRCUIT: PERSPECTIVES AND FUTURE DIRECTIONS
Proopiomelanocortin dendrites, considered the classical sites of
peptidergic and amino acid integration, remain largely unstudied
in POMC neurons. Despite the availability of antisera developed
against classic dendritic markers such as postsynaptic density
95 and the microtubule associated proteins, these markers have
not been identified in POMC neurons. Therefore, it is difficult
to deduce both the neurochemical phenotypes and anatomical
origins of neurons impinging upon POMC cells. In theory, Cre-
dependent expression of dendritic markers specifically in POMC-
Cre neurons may reveal the sites of input to POMC neurons,
but this will depend on the capacity of these cells to express
and target transgenic proteins specifically to dendritic projec-
tions. In addition to classical dendritic inputs, evidence from
the Horvath laboratory suggests that POMC neurons are mod-
ulated by presynaptic neurons directly at the level of the perikarya
(Pinto et al., 2004), which is consistent with chronic nutritional
or hormonal changes altering the axo-dendritic and axo-somatic
contacts in the arcuate nucleus (Parducz et al., 2003; Csakvari
et al., 2007; Horvath et al., 2010). These works present a few
intriguing possibilities regarding the synaptic inputs to the POMC
circuit, primarily that somatic inputs, rather than dendritic inputs,
may contribute significantly to the function of POMC neurons.
Likewise, treating ob/ob mice with leptin was able to attenu-
ate increases in inhibitory synaptic inputs to POMC neurons.
The electrophysiological data combined with electron microscopic
data implicating rapid shifts in the wiring from presynaptic nerve
terminals onto POMC cell bodies over the course of a few hours
suggest an unconventional mode of regulation of POMC neu-
ron activity. However, it is unclear if these somatic inputs are a
primary driver of POMC neuron function. The mechanism under-
lying these rapid alterations in connectivity has not been fully
described.
Furthermore, although the electron microscopic evidence is
compelling, the corresponding electrophysiological data presented
by Pinto et al. (2004) do not completely parallel the anatomic
rearrangements and do not rule out the likelihood that altered
synaptic activity may be more heavily driven at dendritic sites
that were not studied using electron microscopy techniques. The
presence of synaptic inputs to POMC neurons at distal dendrites
has been demonstrated in studies showing that retrograde regula-
tion of POMC neurons by endocannabinoids occurs at GABAergic
synapses impinging on POMC dendrites considerably rostral to
the ARC (Hentges, 2007), emphasizing that these cells indeed
process dendritic inputs at sites distal to the ARC. A possible expla-
nation for the “rewiring” of the circuit may be a shift in POMC
dendrite size or dynamic changes in GABA or glutamate recep-
tor expression on the surface of POMC neurons, similar to the
fasting-induced plasticity of glutamate receptors observed in the
AgRP/NPY circuit (Liu et al., 2012). Nevertheless, there is growing
impetus to parse out how the wiring in the hypothalamus, includ-
ing POMC neurons, can dynamically change when an organism’s
diet or disease state is dramatically shifted (Zeltser et al., 2012).
Because the central POMC circuit is regarded as a primary anorex-
igenic driver, one would expect decreases in POMC neural activity
in a fasted state, enhanced firing in a fed state, and according
to findings from the Horvath group (Pinto et al., 2004; Horvath
et al., 2010), decreased inhibitory inputs to POMC neurons in
ob/ob mice that are treated with leptin. The exact time scale of this
synaptic plasticity and the dysregulation of this circuit in obesity
and other maladies are not known.
On the other hand, if we consider the functional segregation
of the POMC circuit based on three prototypically studied inputs,
the network can also be divided into leptin-, insulin-, or serotonin-
sensitive POMC neurons. Parsing out the respective sensitivity
of different subpopulations of POMC neurons to each of these
inputs suggests that individual POMC neurons are only sensitive
to leptin, insulin, or serotonin (Williams et al., 2010; Sohn et al.,
2011), but to date a handful of POMC neurons are reported to
respond to both insulin and leptin (Al-Qassab et al., 2009). The
entire population of POMC neurons in the mouse CNS totals
only ∼3000 cells, and respective hormone and peptide receptors
likely exist in a dynamic state of fluctuation in terms of expres-
sion, turnover, and desensitization, which makes determining the
total number of neurons sensitive to a given signal a significant
challenge. To date it is unclear if all POMC neurons express recep-
tors for one of these inputs or how the contributions of amino
acid transmitter receptor activation versus peptide signaling bear
on downstream POMC function. Thus, the breadth of how meta-
bolic cues induce the plasticity of the POMC network has not been
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fully deduced, and it remains to be determined how these putative
morphological changes alter different subpopulations of POMC
neurons.
At the axon terminals, many POMC neurons release the amino
acid neurotransmitters GABA and glutamate, whereas all POMC
axonal fibers appear to ubiquitously express the neuropeptides
ACTH, α-MSH, and β-endorphin by immunohistochemical tech-
niques. However, it is not known if peptide and non-peptide
transmitters are released equally from all fibers. Additionally, many
POMC axons have boutons en passant that may release pep-
tides from dense core granules at non-synaptic targets (Buma and
Nieuwenhuys, 1988; Buma et al., 1989; van Lookeren Campagne
et al., 1991). These findings indicate that we still do not have a
full grasp on how opiomelanocortin-derived peptides are released
from POMC neurons, or if these peptides are released equivalently
from all cells. Furthermore, there may be distinct anatomical cor-
relations between POMC subtypes and their CNS effector regions,
but this has not been explicitly determined. If we consider the
phenotypic differences of both the signal integration and peptide
release from the central POMC circuit, there are at least a dozen
possible subpopulations of POMC neurons in the ARC. An acute
or chronic change in nutritional status would be likely to signifi-
cantly alter the synaptic output of subpopulations of the POMC
circuit. For example, the satiety hormone leptin may stimulate
a subset of POMC neurons to predominantly release glutamate
and α-MSH, subsequently reducing food intake and increasing an
animal’s metabolic output. Thus, POMC target sites throughout
the CNS may experience a cocktail of contrasting inputs from
the POMC circuit depending on which phenotypes of cells are
activated in relation to the feeding status of an animal.
Taken together, the integrative aspects of POMC peptide and
synaptic communication are still unclear despite this circuit’s well-
established role in energy balance. Although it is enticing to reduce
the output of the POMC circuit to a small region of the brain,
it is more likely that the POMC network affects multiple tar-
gets throughout the CNS with a dynamic synergy. Future studies
using advanced tools to image fluorophore-labeled POMC pep-
tides at the molecular level may reveal the function of this circuit
in living brain tissue. At this level, peptide synthesis, trafficking,
and release could be monitored in real-time in both acute brain
slices and in live animals. Current reductionist approaches to dis-
sect the POMC circuit seek to parse out the dendritic receptors
and synaptic transmitters expressed by POMC neurons required
to maintain body composition. In many instances these studies
employ Cre/Lox technology to alter the phenotype of the POMC
circuit. Problematically, currently available Pomc-Cre transgenic
mouse lines activate floxed transgenes in both mature POMC
neurons and cells that express Pomc only transiently during devel-
opment (Padilla et al., 2010, 2012). A second Pomc-Cre line was
developed in the lab of Dr. Gregory Barsh (Xu et al., 2005a,b).
The initial characterization of these mice suggested that only 2%
of Cre-positive neurons in the ARC were not POMC neurons.
However, we conducted an independent cell lineage tracing analy-
sis of this alternative Pomc-Cre line crossed to the ROSA26-LacZ
reporter strain and counted ∼8,000 β-galactosidase positive neu-
rons per ARC, a number well in excess of the normally detectable
3,000 immunopositive POMC neurons in an adult mouse (M. J.
Low and A. J. Mercer, unpublished observations). Furthermore,
there was extensive reporter expression in many other non-ARC
hypothalamic nuclei, the zona incerta, and additional extrahypo-
thalamic nuclei similar to the pattern previously reported (Padilla
et al., 2010, 2012) using the Pomc-Cre line created by Dr. Brad
Lowell.
To overcome these developmental issues, researchers have been
employing virally mediated, Cre-dependent expression of chan-
nelrhodopsin proteins in the POMC neurons of adult animals
(Aponte et al., 2011; Yang et al., 2011; Dicken et al., 2012). Cre
expression in adult Pomc-Cre mice appears to be restricted solely
to mature POMC neurons, and thus allows for a more accurate
analysis of the POMC circuit. Activation of channelrhodopsin pro-
teins by light pulses delivered through a guided cannula in vivo or
optically on ex vivo brain slices produces depolarizing membrane
potentials, thus allowing for exogenous control of the POMC
circuit (Tye and Deisseroth, 2012). As discussed previously, opto-
genetic stimulation of POMC neurons in vivo appears to require
a significant amount of time and activation to induce a change
in feeding behavior (Aponte et al., 2011), whereas evoked release
of β-endorphin or the amino acid neurotransmitters GABA and
glutamate can be accomplished within milliseconds or seconds in
an acute brain slice preparation (Yang et al., 2011; Dicken et al.,
2012).
Alternatively, DREADD technology is likely to be capitalized
on for future studies of the POMC circuit (Dong et al., 2010).
Virally mediated, Cre-dependent expression of DREADD recep-
tors can be controlled by synthetic ligands to activate either Gq
or Gi signaling cascades specifically in POMC-Cre neurons. Sim-
ilar to channelrhodopsin-mediated stimulation of AgRP neurons,
activating Gq-coupled DREADDs in AgRP neurons can induce
a potent upregulation of feeding behavior (Krashes et al., 2011).
While channelrhodopsin activation leads to a change in the mem-
brane voltage of a stimulated neuron, DREADD expressing cells
will activate GPCR cascades instead. Together, both technolo-
gies offer artificial mechanisms for directly controlling a single
population of CNS neurons, and eliminate the possibility of off-
target pharmacological effects using intracerebroventricular drug
administration or bath application of drugs on an acute brain
slice. In addition, these technologies may allow us to uncover the
molecular mechanisms governing amino acid neurotransmitter
and POMC peptide release to determine their respective contribu-
tions to POMC-driven anorexia. Deducing the nature of how the
POMC network signals throughout the brain is of critical impor-
tance, as this circuit represents a potential pharmacotherapeutic
target to ameliorate the persistent burden of obesity and its related
metabolic complications.
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